solanezumab

Solanezumab, a new drug created by Eli Lilly has shown promising results in two trails to clear plaques that are believed to be the cause of Alzheimer’s. This is a major achievement for Eli Lilly as there only a few drugs that have been shown to make a difference in delaying this degenerative disease. The […]

Combined results from two studies show that Solanezumab, an Alzheimer’s drug being developed by Eli Lilly & Co., might slow mental decline, particularly in milder Alzheimer’s cases. The results were announced on Monday by researchers at a conference of the American Neurological Association in Boston. While the separate studies showed that the drug did not […]